Target intelligence / Profile preview

SMT3 suppressor of mif two 3 homolog 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

SMT3 suppressor of mif two 3 homolog 2 pseudogene (ENSG00000243659) is a non-protein-coding pseudogene in the human genome[8][3][5]. It is homologous to the yeast SMT3 gene, which is the founding member of the SUMO (Small Ubiquitin-like Modifier) protein family. Functional SUMO proteins (such as SUMO2 and SUMO3) act as post-translational modifiers of other proteins, regulating processes such as nuclear transport, DNA repair, cell cycle progression, and transcriptional regulation. However, this specific pseudogene does not code for a functional protein and is not known to have a direct biological, disease, or therapeutic role in humans[8][3][5][6]. If you are interested in the functional versions, consider searching for SUMO2 or SUMO3 (e.g., "Small ubiquitin like modifier 2" or "Small ubiquitin like modifier 3"), which are active proteins with significant roles in cell biology[6]. The current query, however, points to a pseudogene and not a valid molecular target.

Other names
SMT3H2 pseudogeneSMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogeneSUMO2 pseudogene

Beyond the preview

Go deeper on SMT3 suppressor of mif two 3 homolog 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMT3 suppressor of mif two 3 homolog 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call